248 related articles for article (PubMed ID: 10702232)
1. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis.
Park JS; Kim EJ; Kwon HJ; Hwang ES; Namkoong SE; Um SJ
J Biol Chem; 2000 Mar; 275(10):6764-9. PubMed ID: 10702232
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo.
Um SJ; Rhyu JW; Kim EJ; Jeon KC; Hwang ES; Park JS
Cancer Lett; 2002 May; 179(2):205-12. PubMed ID: 11888675
[TBL] [Abstract][Full Text] [Related]
3. Interaction between interferon regulatory factor-1 and human papillomavirus E7 oncogene in cervical cancer: an ontology study.
Wiwanitkit V
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):138-41. PubMed ID: 19574175
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
Shin MK; Balsitis S; Brake T; Lambert PF
Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1.
Perea SE; Massimi P; Banks L
Int J Mol Med; 2000 Jun; 5(6):661-6. PubMed ID: 10812019
[TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation.
Antonsson A; Payne E; Hengst K; McMillan NA
J Interferon Cytokine Res; 2006 Jul; 26(7):455-61. PubMed ID: 16800784
[TBL] [Abstract][Full Text] [Related]
7. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
8. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
Münger K; Scheffner M; Huibregtse JM; Howley PM
Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
10. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes.
Lace MJ; Anson JR; Haugen TH; Turek LP
Virology; 2010 Apr; 399(2):270-9. PubMed ID: 20129639
[TBL] [Abstract][Full Text] [Related]
13. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression.
Lee SH; Kim JW; Lee HW; Cho YS; Oh SH; Kim YJ; Jung CH; Zhang W; Lee JH
Oncogene; 2003 Jan; 22(3):381-91. PubMed ID: 12545159
[TBL] [Abstract][Full Text] [Related]
15. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
Slebos RJ; Lee MH; Plunkett BS; Kessis TD; Williams BO; Jacks T; Hedrick L; Kastan MB; Cho KR
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5320-4. PubMed ID: 8202487
[TBL] [Abstract][Full Text] [Related]
16. Alteration of Rb binding to HPV 18 E7 modified by transglutaminase 2 with different type of polyamines.
Jeon JH; Cho SY; Kim CW; Shin DM; Jang GY; Lee HJ; Kang HS; Park SC; Kim IG
Front Biosci; 2006 May; 11():1540-8. PubMed ID: 16368535
[TBL] [Abstract][Full Text] [Related]
17. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members.
Duensing S; Münger K
J Virol; 2003 Nov; 77(22):12331-5. PubMed ID: 14581569
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression.
Finzer P; Kuntzen C; Soto U; zur Hausen H; Rösl F
Oncogene; 2001 Aug; 20(35):4768-76. PubMed ID: 11521189
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
Zhou F; Chen J; Zhao KN
J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
